Task: Answer the multiple-choice question.
Query: Which drug exhibits a 10.622% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a.) CCOC(=O)C1(Cc2cccc(F)c2)CCN(C(=O)COC)CC1
b.) O=c1ccc(Cl)n[nH]1
c.) Cc1onc(-c2ccccc2Cl)c1C(=O)NCc1ccc(F)cc1
Answer: c. Cc1onc(-c2ccccc2Cl)c1C(=O)NCc1ccc(F)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1onc(-c2ccccc2Cl)c1C(=O)NCc1ccc(F)cc1
Cc1onc(-c2ccccc2Cl)c1C(=O)NCc1ccc(F)cc1
3-(2-chlorophenyl)-N-[(4-fluorophenyl)methyl]-5-methyl-1,2-oxazole-4-carboxamide